Reelin Depletion is an Early Phenomenon of Alzheimer's Pathology
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Alterations in the expression of Reelin (RELN) have been implicated in the pathology of Alzheimer's disease (AD). However, whether these changes are cause or consequence of AD remains to be resolved. To better understand the role of RELN pathway in the development of AD, we examined the expression profile of RELN and its downstream signaling members APOER2, VLDLR, and DAB1 in AD-vulnerable regions of transgenic and wildtype mice as well as in AD patients and controls across disease stages and/or aging. We show that both AD pathology and aging are associated with perturbation of the RELN pathway in a species-, region-, and molecule-specific manner. Further, we show that depletion of RELN, but not its downstream signaling molecules, is detectable long before the onset of amyloid-β pathology in the murine hippocampus and in a pre-clinical AD stage in the human frontal cortex. This early event hints at a possible causative role of RELN decline in the precipitation of AD pathology and supports RELN's potential as a pre-clinical marker for AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Reelin pathway was recognized to be involved in AD development since its impairment favors amyloidogenic Aβ processing and tau hyperphosphorylation [91,92].”
From The Emerging Role of PCSK9 in the Pathogenesis of Alzheimer’s Disease: A Possible Target for the Disease Treatment (2024) · cites this paper as [92]
In the citing paper
“Altered cleavage of Reelin was also found in AD mice as well as postmortem brain tissue and the cerebrospinal fluid of human AD subjects (89).”
From Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses (2017) · cites this paper as [89]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“AD severity was classified by two neuropathologists utilizing the CERAD [41] and Braak & Braak [42] staging.”
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · cited 1×
“Neuropathologically, AD is characterized by neurofibrillary tangles composed of hyperphosphorylated tau [18] and senile plaques [19], representing”
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 1×
“AD severity was classified by two neuropathologists utilizing the CERAD [41] and Braak & Braak [42] staging.”
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
D'Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H. D., Morgan, J. I., & Curran, T. (1995) · Nature · doi:10.1038/374719a0 · Cited by 1,748 · cited 1×
“During developmental stages, RELN is strongly expressed by Cajal-Retzius neurons [8], enabling proper neocortical lamination and cerebellar foliation [9–12].”
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 1×
“[40] were analyzed at different stages of the disease”
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., & Herz, J. (1999) · Neuron · doi:10.1016/s0896-6273(00)80861-2 · Cited by 916 · cited 2×
“Reelin (RELN) is a highly conserved extracellular glycoprotein with signaling properties, predominantly mediated by the binding of processed RELN fragments to the membranous apolipoprotein E receptor 2 (APOER2, also known as LRP8) and the very low density lipoprotein receptor (VLDLR), which in turn induces the phospho…”
Haass, C., Koo, E. H., Mellon, A., Hung, A. Y., & Selkoe, D. J. (1992) · Nature · doi:10.1038/357500a0 · Cited by 899 · cited 1×
“precursor (A PP) [20].”
Reelin Is a Ligand for Lipoprotein Receptors
D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., & Curran, T. (1999) · Neuron · doi:10.1016/s0896-6273(00)80860-0 · Cited by 808 · cited 1×
“[4, 5] essential for neuronal migration and positioning [6, 7].”
Cited by
Costa, L. G., Cole, T. B., Dao, K., Chang, Y.-C., Coburn, J., & Garrick, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107523 · Cited by 484
“, 2010; Mota, Ferreira, & Rego, 2014b; Yu, Tan, Yu, Xie, & Tan, 2016), and in brains of AD patients, particularly in the early stages (Chin et al., 2007; Herring et al., 2012).”
The involvement of Reelin in neurodevelopmental disorders
Folsom, T. D., & Fatemi, S. H. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.015 · Cited by 275
“…et al. 2003 No change in Reelin expression Increased expression of Reelin 180 kDa in frontal cortex but not cerebellum; altered glycosylation of Reelin Botella López et al. 2006 Reduced expression of Reelin in FC Herring et al. 2012 IR, immunoreactivity; PFC, prefrontal cortex Neuropharmacology.”
BackgroundResultDysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors
Mota, S. I., Ferreira, I. L., & Rego, A. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.013 · Cited by 206
“Additionally to a decrease in mRNA levels, the decrease in GluN2B and GluN2A subunits could be due also to a decrease in reelin levels, a protein that mediates NMDAR activity, and which is depleted in AD brains (Herring et al., 2012).”
Jossin, Y. (2020) · Biomolecules · doi:10.3390/biom10060964 · Cited by 202
Ramanan, V. K., & Saykin, A. J. (2013) · Europe PMC (PubMed Central) · Cited by 251
More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158
“Reelin levels are reduced in the entorhinal cortex in postmortem AD brain and hAPP mouse models (Chin et al., 2007; Herring et al., 2012).”
Gene therapy for neurodegenerative diseases
O’Connor, D. M., & Boulis, N. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.06.001 · Cited by 148
Pujadas, L., Rossi, D., Andrés, R., Teixeira, C. M., Serra-Vidal, B., Parcerisas, A., Maldonado, R., Giralt, E., Carulla, N., & Soriano, E. (2014) · Nature Communications · doi:10.1038/ncomms4443 · Cited by 129
Hinrich, A. J., Jodelka, F. M., Chang, J. L., Brutman, D., Bruno, A. M., Briggs, C. A., James, B. D., Stutzmann, G. E., Bennett, D. A., Miller, S. A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505846 · Cited by 127
“…in Reelin has been shown to be associated with amyloid accumulation, and Reelin overexpression in mice has been shown to improve cognition in mouse models of AD (Chin et al, 2007; Kocherhans et al, 2010; Herring et al, 2012; Cuchillo-Ibanez et al, 2013; Krstic et al, 2013; Pujadas et al, 2014).”
Role of the Extracellular Matrix in Alzheimer’s Disease
Sun, Y., Xu, S., Jiang, M., Liu, X., Yang, L., Bai, Z., & Yang, Q. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.707466 · Cited by 133
“Since reelin depletion occurs before the onset of Aβ pathology, the decline of reelin may play a role in the pathological precipitation of Aβ (Herring et al., 2012).”
BackgroundEmerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
Huang, J.-K., & Lee, H.-C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084300 · Cited by 102
“Reelin depletion is regarded as an early phenomenon in Alzheimer’s disease [172,173], whereas clusterin promotes amyloid beta clearance [32,174,175].”
BackgroundExtracellular matrix proteomics in schizophrenia and Alzheimer’s disease
Sethi, M. K., & Zaia, J. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9900-6 · Cited by 112
“In addition, it was demonstrated that depletion of reelin is an early event of AD, occurring long before the onset of Aβ plaques, suggesting a possible role of decreased reelin expression in precipitation of AD and supporting it as a potential preclinical marker of AD [128].”
Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses
Wasser, C. R., & Herz, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.766782 · Cited by 111
“Altered cleavage of Reelin was also found in AD mice as well as postmortem brain tissue and the cerebrospinal fluid of human AD subjects (89).”
BackgroundMicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites
Bicker, S., Lackinger, M., Weiß, K., & Schratt, G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1671-7 · Cited by 102
Krstic, D., Rodriguez, M., & Knuesel, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047793 · Cited by 90
“In addition, in several brain disorders, including AD, Reelin protein levels, its post-translational modifications, and Reelin proteolytic processing are found to be dysregulated [7-11].”
BackgroundTargeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease
Haberman, R. P., Branch, A., & Gallagher, M. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0541-z · Cited by 93
“Loss of EC reelin is also seen in mouse models of FAD and in patients with AD, consistent with the well-known vulnerability of neurons in layer 2 of the EC [123, 124].”
ResultSziraki, A., Lu, Z., Lee, J., Banyai, G., Anderson, S., Abdulraouf, A., Metzner, E., Liao, A., Banfelder, J., Epstein, A., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01572-y · Cited by 92
“The expression of Reln 62 decreased in various cell types in both models, aligning with previous report of Reln depletion before the onset of amyloid-beta pathology in the human frontal cortex 63 .”
BackgroundDab1 Is Required for Synaptic Plasticity and Associative Learning
Trotter, J., Lee, G. H., Kazdoba, T. M., Crowell, B., Domogauer, J., Mahoney, H. M., Franco, S. J., Müller, U., Weeber, E. J., & D'Arcangelo, G. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2010-13.2013 · Cited by 90
The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor
Dlugosz, P., & Nimpf, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103090 · Cited by 91
“Reelin depletion seems to be an early phenomenon of AD pathology and is detectable long before Aβ pathology becomes evident [108]; although, they are conflicting results concerning this phenomenon (see later).”
ResultECM in brain aging and dementia
Morawski, M., Filippov, M., Tzinia, A., Tsilibary, E., & Vargova, L. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00010-4 · Cited by 84
“Recent data indicate that both AD pathology and aging are associated with perturbation of the reelin pathway in a species-, region-, and molecule-specific manner (Herring et al., 2012).”
Kobro-Flatmoen, A., Nagelhus, A., & Witter, M. P. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.012 · Cited by 80
Ding, Y., Huang, L., Xian, X., Yuhanna, I. S., Wasser, C. R., Frotscher, M., Mineo, C., Shaul, P. W., & Herz, J. (2016) · Science Signaling · doi:10.1126/scisignal.aad5578 · Cited by 72
“Experimental and clinical studies indicate that increased Reelin abundance is protective (14– 16), while reduced Reelin abundance in the brain is associated with several neurodegenerative disorders including Alzheimer’s disease (AD) (17–20).”
Hisanaga, A., Morishita, S., Suzuki, K., Sasaki, K., Koie, M., Kohno, T., & Hattori, M. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.017 · Cited by 56
“Accordingly, dysfunction of Reelin is involved in the pathogenesis of several neuronal diseases including Alzheimer’s disease [5,6] and schizophrenia [7,8].”
BackgroundProgressive signaling changes in the olfactory nerve of patients with Alzheimer's disease
Bathini, P., Mottas, A., Jaquet, M., Brai, E., & Alberi, L. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.12.006 · Cited by 59
“On the other hand, another article shows that Reelin levels decline with the progression of dementia in neurons of the frontal cortices, hippocampus, and entorhinal cortex (Herring et al., 2012).”
BackgroundEph receptors: New players in Alzheimer's disease pathogenesis
Cissé, M., & Checler, F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.028 · Cited by 46
“Furthermore, Reelin levels are reduced in hAPP transgenicmice and inAD (Chin et al., 2007;Herring et al., 2012), and overexpressing Reelin delayed amyloid plaque formation and rescued memory deficits in mice carrying the APPSwe/Ind mutation (J20 mice) (Pujadas et al., 2014).”
BackgroundThe β-amyloid peptide compromises Reelin signaling in Alzheimer’s disease
Cuchillo-Ibañez, I., Mata-Balaguer, T., Balmaceda, V., Arranz, J. J., Nimpf, J., & Sáez-Valero, J. (2016) · Scientific Reports · doi:10.1038/srep31646 · Cited by 47
Jha, S. K., Jha, N. K., Kumar, D., Sharma, R., Shrivastava, A., Ambasta, R. K., & Kumar, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160623 · Cited by 53
Reelin Signaling in Neurodevelopmental Disorders and Neurodegenerative Diseases
Joly‐Amado, A., Kulkarni, N., & Nash, K. R. (2023) · Brain Sciences · doi:10.3390/brainsci13101479 · Cited by 51
The Role of Reelin Signaling in Alzheimer’s Disease
Yu, N., Tan, M., Yu, J., Xie, A., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9459-9 · Cited by 51
“drastically reduced levels of Reelin protein in the brain in humans [22] are prominent immunohistochemical features seen already in early stages of AD.”
Yang, G., & Shcheglovitov, A. (2019) · Developmental Dynamics · doi:10.1002/dvdy.100 · Cited by 47
Extracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation
Trotter, J. H., Lussier, A. L., Psilos, K. E., Mahoney, H. L., Sponaugle, A., Hoe, H., Rebeck, G. W., & Weeber, E. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.046 · Cited by 44
“…neurodegenerative disorders, including schizophrenia (Impagnatiello et al., 1998; Fatemi et al., 2000), depression (Fatemi et al., 2000; Lussier et al., 2009; Lussier et al., 2011; Lussier et al., 2013), and Alzheimer’s disease (Chin et al., 2007; Botella-Lopez et al., 2010; Herring et al., 2012).”
BackgroundAlzheimer's disease: an evolutionary approach.
Bufill, E., Blesa, R., & Augustí, J. (2013) · PubMed · doi:10.4436/jass.91001 · Cited by 40
“This suggests the possible causative role of reelin decline in the precipitation of AD (Herring et al., 2012).”
Reelin links Apolipoprotein E4, Tau, and Amyloid‐β in Alzheimer’s disease
Yi, L. X., Zeng, L., Wang, Q., Tan, E. K., & Zhou, Z. D. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102339 · Cited by 41
Early onset senescence and cognitive impairment in a murine model of repeated mTBI
Schwab, N., Ju, Y., & Hazrati, L.-N. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01190-x · Cited by 39
“RELN expression decreases early in AD prior to the deposition of amyloid pathology [59], and its loss is associated with cognitive deficits, several neuropsychiatric disorders, and loss of synapse maintenance [65].”
BackgroundNeuronal chemo‐architecture of the entorhinal cortex: A comparative review
Kobro‐Flatmoen, A., & Witter, M. P. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14511 · Cited by 44
“terminal distributions in the hippocampus (Herring et al., 2012; Miettinen et al., 2005; Ramos‐Moreno et al., 2006).”
BackgroundMota, S. I., Ferreira, I. L., Valero, J., Ferreiro, E. B., Carvalho, A. L., Oliveira, C. R., & Rego, A. C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.023 · Cited by 41
“Importantly, reelin was shown to be depleted in AD brain before the onset of Aβ pathology in AD transgenic mice hippocampus and in human frontal cortex at pre-clinical AD stage (Herring et al., 2012).”
BackgroundKrstic, D., & Knuesel, I. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-62 · Cited by 35
“Important, compared to age-matched controls, Reelin levels are significantly lower in AD patients already at early stages of the disease [100,101], but in high-pathology non-demented individuals Reelin production is increased [98].”
BackgroundRapid Aging in the Perforant Path Projections to the Rodent Dentate Gyrus
Amani, M., Lauterborn, J. C., Le, A. A., Cox, B. M., Wang, W., Quintanilla, J., Cox, C. D., Gall, C. M., & LYNCH, G. S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2376-20.2021 · Cited by 40
“Reelin levels are altered in AD (Botella-López et al., 2006; Chin et al., 2007; Doehner and Knuesel, 2010; Herring et al., 2012) and are reduced in LEC of 24-month-old rats but only in cases with impaired learning (Stranahan et al., 2011).”
BackgroundReelin Signaling Pathway Genotypes and Alzheimer Disease in a Spanish Population
Bufill, E., Poch, P. R., Sala, I., Antón‐Aguirre, S., Lleó, A., Sánchez‐Saudinós, M. B., Tomàs-Abadal, L., Puig, T., Abós, J., Bernades, S., et al. (2014) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000002 · Cited by 37
Reelin in Alzheimer’s Disease, Increased Levels but Impaired Signaling: When More is Less
Cuchillo‐Ibáñez, I., Balmaceda, V., Mata‐Balaguer, T., López‐Font, I., & Sáez‐Valero, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151193 · Cited by 37
“Finally, a decrease in Reelin protein levels was detected in several brain areas of AD subjects, although these changes did not reach significance at the transcriptional levels [37].”
InfluentialIdentification of exon skipping events associated with Alzheimer’s disease in the human hippocampus
Initiative, A. D. N., Han, S., Miller, J. E., Byun, S., Kim, D., Risacher, S. L., Saykin, A. J., Lee, Y., & Nho, K. T. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0453-8 · Cited by 36
Decisive role of Reelin signaling during early stages of Alzheimer’s disease
Krstic, D., Pfister, S., Notter, T., & Knuesel, I. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.042 · Cited by 36
“2), we propose that reduction of Reelin (Chin et al., 2007; Herring et al., 2012a), as a consequence of cumulative environmental injuries to the olfactory pathway (Okuyama-Yamamoto et al., 2005) or injury/disease/infection-induced chronic inflammation (Knuesel et al., 2009; Krstic and Knuesel,…”
InfluentialReelin proteolysis affects signaling related to normal synapse function and neurodegeneration
Lussier, A. L., Weeber, E. J., & Rebeck, G. W. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00075 · Cited by 31
“Altered Reelin signaling has been linked to AD through analyses of human brain samples (Herring et al., 2012; Notter and Knuesel, 2013), and animal models connecting Reelin to the processes of amyloid accumulation (Chin et al.”
BackgroundReelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy
Rossi, D., Gruart, A., Contreras-Murillo, G., Muhaisen, A., Ávila, J., Delgado-García, J. M., Pujadas, L., & Soriano, E. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101743 · Cited by 30
“Of note, both in the J20 AD mouse model (carrying the Swedish and the Indiana mutations of the human Amyloid Precursor Protein) and in AD patients, depletion of Reelin has been reported as one of the early events in this pathology [13, 14].”
BackgroundLong, J. M., Perez, E., Roberts, J. A., Roberts, M. T., & Rapp, P. R. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.010 · Cited by 30
“Disrupted reelin signaling has been implicated in a variety of conditions in which cognition is prominently affected, including schizophrenia and Alzheimer’s disease (AD) (Guidotti et al., 2000; Herring et al., 2012; Impagnatiello et al., 1998; Kramer et al., 2011; Seripa et al., 2008).”
BackgroundInhibition of excessive kallikrein-8 improves neuroplasticity in Alzheimer's disease mouse model
Münster, Y., Keyvani, K., & Herring, A. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113115 · Cited by 31
Self-citationNotter, T., & Knuesel, I. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-27 · Cited by 28
“It is therefore plausible, that the decrease in Reelin levels during aging [28,32,33] with its concomitant in- and decrease in Tau [12,52] and n-cofilin phosphorylation [22], respectively, may reduce axonal and dendritic cytoskeletal stabilities and strongly impair transport from and to synaptic sites.”
A Perspective on the Role of microRNA-128 Regulation in Mental and Behavioral Disorders
Ching, A.-S., & Ahmad-Annuar, A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00465 · Cited by 24
Presenilin 1 mutations influence processing and trafficking of the ApoE receptor apoER2
Wang, W., Moerman, A., Slaton, A., & Barger, S. W. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.005 · Cited by 24
“These impacts of ApoE4 and PS1 mutation may have more significant consequences when Reelin levels are reduced, as is evident in the entorhinal cortex and hippocampus in mouse models of AD and frontal cortex in patients with preclinical AD (Chin et al., 2007; Herring et al., 2012).”
BackgroundThe Effects of Alpha Boswellic Acid on Reelin Expression and Tau Phosphorylation in Human Astrocytes
Fathi, E., Katouli, F. H., Riazi, G. H., Shasaltaneh, M. D., Parandavar, E., Bayati, S., Afrasiabi, A., & Nazari, R. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8437-3 · Cited by 23
Neely, B. A., Soper, J. L., Gulland, F. M. D., Bell, P. D., Kindy, M. S., Arthur, J. M., & Janech, M. G. (2015) · PROTEOMICS · doi:10.1002/pmic.201500167 · Cited by 23
“Additional studies have shown that reelin is depressed in models of schizophrenia [94, 95], Alzheimer’s disease [96], and epilepsy [97], but have not been measured in studies of domoic acid-induced neurotoxicity.”
ResultKarim, S., Mirza, Z., Ansari, S. A., Rasool, M., Iqbal, Z., Sohrab, S. S., Kamal, M. A., Abuzenadah, A. M., & Al-Qahtani, M. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917113446 · Cited by 23
Ramsden, C. E., Keyes, G. S., Calzada, E., Horowitz, M. S., Zamora, D., Jahanipour, J., Sedlock, A., Indig, F. E., Moaddel, R., Kapogiannis, D., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220071 · Cited by 19
Reive, B. S., Johnston, J. N., Sánchez-Lafuente, C. L., Zhang, L., Chang, A., Zhang, J., Allen, J., Romay-Tallón, R., Kalynchuk, L. E., & Caruncho, H. J. (2023) · Chronic Stress · doi:10.1177/24705470231164920 · Cited by 18
“18,19 20 – 27 Altered expression and methylation of Reelin in peripheral blood is seen in various disease states.”
BackgroundTesta, G., Giannelli, S., Staurenghi, E., Cecci, R., Floro, L., Gamba, P., Sottero, B., & Leonarduzzi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413637 · Cited by 16
“The Reelin pathway was recognized to be involved in AD development since its impairment favors amyloidogenic A β processing and tau hyperphosphorylation [91,92].”
Mroczek, M., Clark, C., Dayon, L., Bowman, G. L., & Popp, J. (2022) · Cells · doi:10.3390/cells11061030 · Cited by 16
“RELN is involved in the APOE biochemical pathway and inhibits regulators of tau phosphorylation [48,49].”
BackgroundThe Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer’s Disease
Reive, B. S., Lau, V. Z., Sánchez-Lafuente, C. L., Henri‐Bhargava, A., Kalynchuk, L. E., Tremblay, M., & Caruncho, H. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240088 · Cited by 15
Cancer and Alzheimer’s Inverse Correlation: an Immunogenetic Analysis
Bhardwaj, A., Liyanage, S. I., & Weaver, D. F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03260-8 · Cited by 15
Sexually Dimorphic Expression of Reelin in the Brain of a Mouse Model of Alzheimer Disease
Palladino, G., Nicolia, V., Kovács, G. G., Canterini, S., Ciraci, V., Fuso, A., Mangia, F., Scarpa, S., & Fiorenza, M. T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0865-x · Cited by 15
“Higher reelin expression of TgCRND8 mouse hippocampi extends to all three reelin forms (Koie et al. 2014; Herring et al. 2012) and is consistently observed in the various hippocampal regions (Table 1), as indicated by western blot and immunohistochemistry, respectively.”
BackgroundKiroski, I., Jiang, Y., Gavrilovici, C., Gao, F., Lee, S., Scantlebury, M. H., Vandal, M., Park, S. K., Tsai, L., Teskey, G. C., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa088 · Cited by 15
“Finally, Reelin expression is altered in Alzheimer’s disease (Botella-Lopez et al. 2006; Herring et al. 2012) and its protective effects are antagonized by amyloid-β toxicity (Pujadas et al.”
BackgroundDisease-Specific Changes in Reelin Protein and mRNA in Neurodegenerative Diseases
Lidón, L., Urrea, L., Llorens, F., Gil, V., Álvarez, I., Díez-Fairén, M., Aguilar, M., Pástor, P., Zerr, I., Alcolea, D. A., et al. (2020) · Cells · doi:10.3390/cells9051252 · Cited by 17
“The RELN changes are in line with some published studies [33,40] but in contrast with [12].”
ResultCosta, L. G. (2017) · Advances in neurotoxicology · doi:10.1016/bs.ant.2017.07.001 · Cited by 17
Neurotoxicity of air pollution: Role of neuroinflammation
Costa, L. G., Cole, T. B., Dao, K., Chang, Y. C., Coburn, J. L., & Garrick, J. M. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.007 · Cited by 13
López‐Font, I., Lennol, M. P., Iborra‐Lázaro, G., Zetterberg, H., Blennow, K., & Sáez‐Valero, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147522 · Cited by 12
“It is worth mentioning that some studies have found contradictory results in which decreased reelin expression was associated with AD [42,43].”
ResultRegulation of the hippocampal translatome by Apoer2-ICD release
Wasser, C. R., Werthmann, G. C., Hall, E. M., Kuhbandner, K., Wong, C. H. Y., Durakoglugil, M. S., & Herz, J. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00652-1 · Cited by 12
“Functional Reelin expression is altered in AD [6, 12, 37], and its protective effects are antagonized by Aβ toxicity [51, 68].”
BackgroundKang, Z.-C., Wang, H.-G., Yang, Y.-L., Zhao, X., Zhou, Q., Yang, Y., Yang, J., & Du, G. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s249176 · Cited by 10
REELIN ameliorates Alzheimer's disease, but how?
Katsuyama, Y., & Hattori, M. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.07.004 · Cited by 9
“…of Reelin was detectable long before the onset of histological AD pathology in the murine hippocampus and in a pre-clinical AD stage in the human frontal cortex (Herring et al., 2012), whereas a research reported increased REELIN expression in advanced AD brains (Mata-Balaguer et al., 2018).”
BackgroundReive, B. S., Johnston, J. N., Sánchez-Lafuente, C. L., Scheil, K., Kurz, K., Kalynchuk, L. E., & Caruncho, H. J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1368620 · Cited by 9
Islam, R., Jackson, B., Naomi, M. T., Schatz, B., Tan, N., Murdock, M. H., Park, D. S., Rodrígues-Amorím, D., Jiang, X., Pineda, S. S., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317428 · Cited by 9
“Among those, Reln in particular has been implicated in AD [33,34] and aging [35], and a gain-of-function variant in this gene has been shown to confer resilience against autosomal dominant AD Based on these observations and to further validate the significance of the three gene modules in cognitive…”
Uysal, M., Çelikten, M., Beker, M., Polat, N., Hüseyinbaş, Ö., Uşak, Ş. T., & Elibol, B. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-2427 · Cited by 10
“In previous studies, a decrease in the level of reelin was noted in both the early phase of AD and before the onset of amyloid pathology (Chin et al., 2007; Herring et al., 2012).”
BackgroundMa, Y., Zhang, J., Liu, H., Li, D., Guo, S., Han, J., Wang, L., Yu, S., Su, X., Gao, Y., et al. (2025) · Protein & Cell · doi:10.1093/procel/pwaf042 · Cited by 8
Assessment of expression of RELN signaling pathway in multiple sclerosis patients
Talebian, S., Gharesouran, J., Ghafouri‐Fard, S., Esfahani, B. S., Arsang‐Jang, S., Omrani, M. D., Taheri, M. N., & Rezazadeh, M. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.02.007 · Cited by 8
OCRL1 Deficiency Affects the Intracellular Traffic of ApoER2 and Impairs Reelin-Induced Responses
Fuentealba, L. M., Pizarro, H., & Marzolo, M. (2024) · Biomolecules · doi:10.3390/biom14070799 · Cited by 5
“Regarding neurodegeneration, murine models of Alzheimer’s disease (AD) show an early decline of Reelin in the hippocampus and cortex [117,118], and human brains of AD patients have lower Reelin levels [117,119].”
BackgroundShao, X., Yang, Y., Chen, J., Zhao, R., Xu, L., Guo, X., Feng, Y., & Qin, L. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/6766460 · Cited by 5
“Decrease of RELN expression is an early phenomenon of AD’s pathology [37].”
BackgroundLogue, M. W., Labadorf, A. T., O’Neill, N. K., Dickson, D. W., Dugger, B. N., Flanagan, M. E., Frosch, M. P., Gearing, M., Jin, L., Kofler, J., et al. (2024) · medRxiv · doi:10.1101/2024.10.29.24316311 · Cited by 6
Relevance of a Novel Circuit-Level Model of Episodic Memories to Alzheimer’s Disease
Kovács, K. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010462 · Cited by 5
“Change of reelin expression in AD patients 2003 protein increase in the cerebrospinal fluid [17] 2006 protein, mRNA increase in the frontal cortex [18] 2007 protein decrease in the entorhinal cortex [19] 2010 protein increase in the frontal cortex [20] 2012 protein, mRNA decrease in the entorhinal cortex [21]”
BackgroundLogue, M. W., Labadorf, A. T., O’Neill, N. K., Dickson, D. W., Dugger, B. N., Flanagan, M. E., Frosch, M. P., Gearing, M., Jin, L., Kofler, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70629 · Cited by 7
Mata, Á., Urrea, L., Vilches, S., Llorens, F., Thüne, K., Espinosa, J. C., Andréoletti, O., Sevillano, A. M., Torres, J. M., Requena, J. R., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0177-8 · Cited by 5
Biomarkers of Disorders of the Nervous System
Jain, K. K. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7431-3_14 · Cited by 4
The Alzheimer risk factor CD2AP causes dysfunction of the brain vascular networkPreprint
Vandal, M., Institóris, Á., Korin, B., Gunn, C., Lee, S., Lee, J. Y., Bourassa, P., Mishra, R. C., Peringod, G., Jiang, Y., et al. (2020) · Research Square · doi:10.1101/2020.12.10.419598 · Cited by 2
Daniel, A., Palacios-García, I., & González-Billault, C. E. (2013) · InTech eBooks · doi:10.5772/54038 · Cited by 1
Reive, B. S., Halvorson, C., Chang, A., Allen, J., Romay-Tallón, R., Kalynchuk, L. E., & Caruncho, H. J. (2026) · Glial health research. · doi:10.1016/j.ghres.2026.100019 · Cited by 1
Analysis of Reelin function in the molecular mechanisms underlying Alzheimer’s disease
Rossi, D. P. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Knuesel, I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00004-2
Genes, Aging, and Parkinson’s Disease
Milanese, C., & Mastroberardino, P. G. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00389
Acute effects of LGI1 on network excitability
Lugarà, E. (2019) · UCL Discovery (University College London)
MiR-384 Regulates Reelin by Inhibiting ADAMTS4 in Neuronal Cell LinesPreprint
Cao, Q., Huang, B., Wang, P., Zhao, G., Zhao, M., & Yu, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.04.447133
Čurčić, J., Racetin, A., Kelam, N., & Vukojević, K. (2022) · Annals of biomedical and clinical research · doi:10.47960/2744-2470.2022.1.1.12
Sandberg, A. A., Puttagunta, S., Duval, N., Fleming, H., Koza, L. A., Hieber, K., Holsopple, J., Reyna, M., Paredes, D., & Linseman, D. A. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251338323 · Cited by 1
Very low-density lipoprotein and the human health
Bharadwaj, A., Taneja, M., Dubey, S., & Saxena, A. (2026) · World Journal of Experimental Medicine · doi:10.5493/wjem.v16.i1.117024
“While reelin depletion is considered an early event in Alzheimer’s disease[119,120], clusterin promotes the removal of amyloid-β [121,122].”
Jacquelin, C. (2015) · theses.fr (ABES) · doi:10.70675/12f30237z2e4cz45f5z8bb5z6c1126f679fb
Maleki, Z., Mirshekar, M. A., Montazerifar, F., Etminani, B., & Keykha, F. (2026) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/7185647
“Previous studies have indicated that reelin loss can precede the onset of A β pathology in the mouse hippocampus and in pre-clinical human cortical regions [51].”
Uşak, Ş. T., Zaim, M., Beker, M., Işık, S., & Elibol, B. (2026) · Experimental Brain Research · doi:10.1007/s00221-026-07339-1
“Likewise, reduced reelin expression has been identified as an early event in the frontal cortex of AD patients (Herring et al. 2012).”
Halvorson, C. S., Reive, B. S., Thom, S. A., Teevens, C. M., Han, J., Kalynchuk, L. E., & Caruncho, H. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.09.750432
Metadata
- Authors
- Herring, A., Donath, A., Steiner, K. M., Widera, M. P., Hamzehian, S., Kanakis, D., Kölble, K., ElAli, A., Hermann, D. M., Paulus, W., & Keyvani, K.
- Affiliations
- Essen University Hospital (DE)
- University Hospital Münster (DE)
- Corresponding author
- Keyvani, Kathy
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2012-06-18
- Volume
- 30
- Issue
- 4
- Pages
- 963-979
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1537020271
- Cited by
- 92
- References
- 51
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 4 · 2016: 13 · 2015: 5 · 2014: 9 · 2013: 9 · 2012: 3
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- reelin, Alzheimer's disease
- MeSH terms
- Reelin Protein, Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Female, Frontal Lobe, Humans, Male, Mice, Inbred C3H, Mice, Inbred C57BL, Mice, Transgenic, Nerve Tissue Proteins, Serine Endopeptidases, Biomarkers, Cell Adhesion Molecules, Neuronal, Extracellular Matrix Proteins, Early Diagnosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.